Compare MEDINET Co., Ltd. with Similar Stocks
Dashboard
1
Poor Management Efficiency with a low ROE of 0%
- The company has reported losses. Due to this company has reported negative ROE
2
Poor long term growth as Net Sales has grown by an annual rate of 4.64% over the last 5 years
3
Flat results in Mar 26
4
Risky -
5
Consistent Underperformance against the benchmark over the last 3 years
Stock DNA
Pharmaceuticals & Biotechnology
JPY 7,490 Million (Micro Cap)
NA (Loss Making)
NA
0.00%
-0.82
-33.10%
2.10
Revenue and Profits:
Net Sales:
233 Million
(Quarterly Results - Mar 2026)
Net Profit:
-212 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-26.47%
0%
-26.47%
6 Months
-35.9%
0%
-35.9%
1 Year
-44.44%
0%
-44.44%
2 Years
-63.24%
0%
-63.24%
3 Years
-64.79%
0%
-64.79%
4 Years
-56.9%
0%
-56.9%
5 Years
-79.51%
0%
-79.51%
MEDINET Co., Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
4.64%
EBIT Growth (5y)
-8.30%
EBIT to Interest (avg)
-696.12
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.87
Sales to Capital Employed (avg)
0.17
Tax Ratio
0.31%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
2.41
EV to EBIT
-3.78
EV to EBITDA
-4.06
EV to Capital Employed
9.38
EV to Sales
6.88
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-248.32%
ROE (Latest)
-39.76%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
Bearish
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
No Trend
No Trend
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ
Mar'26
Dec'25
Change(%)
Net Sales
232.90
181.20
28.53%
Operating Profit (PBDIT) excl Other Income
-234.40
-347.50
32.55%
Interest
0.00
2.90
-100.00%
Exceptional Items
-31.90
1.20
-2,758.33%
Consolidate Net Profit
-212.10
-339.30
37.49%
Operating Profit Margin (Excl OI)
-1,111.00%
-2,048.70%
93.77%
USD in Million.
Net Sales
QoQ Growth in quarter ended Mar 2026 is 28.53% vs -23.71% in Dec 2025
Consolidated Net Profit
QoQ Growth in quarter ended Mar 2026 is 37.49% vs -35.56% in Dec 2025
Annual Results Snapshot (Consolidated) - Sep'25
Sep'25
Sep'24
Change(%)
Net Sales
810.30
768.50
5.44%
Operating Profit (PBDIT) excl Other Income
-1,343.90
-1,271.70
-5.68%
Interest
0.00
0.00
Exceptional Items
10.60
-10.50
200.95%
Consolidate Net Profit
-1,362.10
-1,277.00
-6.66%
Operating Profit Margin (Excl OI)
-1,783.90%
-1,753.50%
-3.04%
USD in Million.
Net Sales
YoY Growth in year ended Sep 2025 is 5.44% vs 16.18% in Sep 2024
Consolidated Net Profit
YoY Growth in year ended Sep 2025 is -6.66% vs 11.20% in Sep 2024
About MEDINET Co., Ltd. 
MEDINET Co., Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






